Skip to main content
. 2018 Dec 18;38(6):BSR20181389. doi: 10.1042/BSR20181389

Figure 2. Effect of EPAS1 mutations on VEGF transcription.

Figure 2

The dual-luciferase assay was performed to evaluate VEGF promoter activity. Cells were grown in conditions of normoxia (DFO-) or hypoxia (DFO+) for 24 h. The HIF2 N203H mutation significantly affected HIF2-mediated VEGF transcription, especially in conditions of hypoxia. ***p<0.001 vs. empty vector; #p<0.05; ###p<0.001 vs. wild-type (Student’s t-test).